Form D Explorer
LIPELLA PHARMACEUTICALS INC. · CIK 1347242

Report a data issueCitable research briefCompare issuerPrivate research collection

LIPELLA PHARMACEUTICALS INC.

CIK 1347242 · Corporation · Inc. DELAWARE · PITTSBURGH, Pennsylvania · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Jan 7, 2025
through Apr 1, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJan 7, 2025 · DApr 1, 2025 · DLater minus earlier
Reported offering amount$6,000,000$9,000$-5,991,000
Reported amount sold$2,597,500$9,000$-2,588,500
Reported investor count———
Reported minimum investment$50,000$0$-50,000

Earlier SEC source: 0001753926-25-000060 · Later SEC source: 0001753926-25-000541

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Apr 1, 2025

Reported offering amount
$9,000
Reported exemptions
Rule 506(b)
Reported amount sold
$9,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)